- Home
- GTI vs COEP Comparison
GTI vs COEP Comparison
Compare GTI & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTI
- COEP
- Stock Information
- Founded
- GTI 2019
- COEP 2017
- Country
- GTI Malaysia
- COEP United States
- Employees
- GTI N/A
- COEP N/A
- Industry
- GTI
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GTI
- COEP Health Care
- Exchange
- GTI NYSE
- COEP Nasdaq
- Market Cap
- GTI 28.2M
- COEP 30.5M
- IPO Year
- GTI N/A
- COEP N/A
- Fundamental
- Price
- GTI $0.10
- COEP $9.48
- Analyst Decision
- GTI
- COEP
- Analyst Count
- GTI 0
- COEP 0
- Target Price
- GTI N/A
- COEP N/A
- AVG Volume (30 Days)
- GTI 11.5M
- COEP 41.9K
- Earning Date
- GTI 05-15-2025
- COEP 05-09-2025
- Dividend Yield
- GTI N/A
- COEP N/A
- EPS Growth
- GTI N/A
- COEP N/A
- EPS
- GTI N/A
- COEP N/A
- Revenue
- GTI N/A
- COEP N/A
- Revenue This Year
- GTI N/A
- COEP N/A
- Revenue Next Year
- GTI N/A
- COEP N/A
- P/E Ratio
- GTI N/A
- COEP N/A
- Revenue Growth
- GTI N/A
- COEP N/A
- 52 Week Low
- GTI $0.08
- COEP $2.31
- 52 Week High
- GTI $11.09
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- GTI 32.76
- COEP 44.36
- Support Level
- GTI $0.08
- COEP $9.01
- Resistance Level
- GTI $0.13
- COEP $9.75
- Average True Range (ATR)
- GTI 0.02
- COEP 0.89
- MACD
- GTI 0.01
- COEP -0.07
- Stochastic Oscillator
- GTI 30.36
- COEP 42.98
About GTI GRAPHJET TECHNOLOGY
Graphjet Technology is a company that owns state-of-the-art technology for the manufacture of artificial graphene and graphite, critical raw materials used in a variety of industries. The technology was developed through our collaboration with National University of Malaysia and Universiti Teknikal Malaysia Melaka. It produces artificial graphite and graphene from palm seed kernels, a waste product widely available in Malaysia and other countries that produce palm seed oil. Unlike mineral coal-based or petroleum-based graphite which is ultimately limited and must be mined and processed to produce commercial-grade graphite, our raw materials are renewable and effectively unlimited.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.